The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic factors for survival in the phase III TROPIC trial.
A. Oliver Sartor
Honoraria - Sanofi
Stéphane Oudard
Consultant or Advisory Role - Sanofi
Mustafa Ozguroglu
No relevant relationships to disclose
Steinbjorn Hansen
Consultant or Advisory Role - Sanofi
Jean-Pascal H. Machiels
Consultant or Advisory Role - Sanofi
Honoraria - Sanofi
Ivo Kocak
No relevant relationships to disclose
Gwenaelle Gravis
No relevant relationships to disclose
Istvan Bodrogi
No relevant relationships to disclose
Mary J. MacKenzie
No relevant relationships to disclose
Francisco Jorquera Orlandi
Consultant or Advisory Role - Sanofi
Honoraria - Sanofi
Liji Shen
Employment or Leadership Position - Sanofi
Stock Ownership - Sanofi
Johann Sebastian De Bono
Consultant or Advisory Role - Sanofi
Honoraria - Sanofi